-
Founded in:
2001-11-30 -
Country:
China -
Address:
Luoqi Road, Linyi High-tech Industrial Development Zone, Shandong Province -
Tax NO.:
913700002658705037 -
Registered Funds:
60.96 million yuan -
Website:
-
Email:
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Carbazochrome sodium sulfonate |
This product can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability.
More
This product can reduce capillary permeability, enhance the retraction effect of broken capillary ends, and increase the resistance of capillaries to damage. It is often used for various types of bleeding caused by increased capillary permeability. |
51460-26-5 | 33 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Oxaliplatin |
This product has the general toxicity of platinum compounds, species-specific cardiac toxicity, and no cisplatin-like renal toxicity or carboplatin-like bone marrow toxicity. This product acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. This product binds to DNA rapidly, taking up to 15 minutes, and can inhibit DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis, and is effective against certain cell lines resistant to cisplatin.
More
This product has the general toxicity of platinum compounds, species-specific cardiac toxicity, and no cisplatin-like renal toxicity or carboplatin-like bone marrow toxicity. This product acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. This product binds to DNA rapidly, taking up to 15 minutes, and can inhibit DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis, and is effective against certain cell lines resistant to cisplatin. |
61825-94-3 | 56 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Oxaliplatin |
This product has the general toxicity of platinum compounds, with species-specific cardiotoxicity, but does not have the renal toxicity of cisplatin and the bone marrow toxicity of carboplatin. This product acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. It binds to DNA quickly, taking up to 15 minutes, and can inhibit DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis, and is effective against certain cell lines resistant to cisplatin.
More
This product has the general toxicity of platinum compounds, with species-specific cardiotoxicity, but does not have the renal toxicity of cisplatin and the bone marrow toxicity of carboplatin. This product acts on DNA by producing alkylated conjugates, forming intra-chain and inter-chain crosslinks, thereby inhibiting DNA synthesis and replication. It binds to DNA quickly, taking up to 15 minutes, and can inhibit DNA synthesis during replication, subsequent DNA separation, RNA and cell protein synthesis, and is effective against certain cell lines resistant to cisplatin. |
61825-94-3 | 56 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefmetazole sodium |
None
More
None |
56796-39-5 | 14 |
| Name | Description | Content | CAS NO. | Registered Holders |
|---|---|---|---|---|
| Cefmetazole sodium |
None
More
None |
56796-39-5 | 14 |